Pharma making strides in AI use
The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
2025: A Defining Year For The Healthcare Supply Chain
With technological advancements, shifting patient expectations and ongoing pressures for resilience, we face both challenges ...
Supply Chain14h
U.S. Pharma Companies Weigh a Shift to North America — and Possibly the U.S. — for Drug Production
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
STAT10h
The FDA’s misguided thinking on antibiotics
You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...
Pharmacies are fed up with PBMs. Here’s what reforms might be coming
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...